Plain-English translation of NCT07724496 on ClinicalTrials.gov ↗ ·
This is an observational study that examines the relationship between a bacterial infection called Helicobacter pylori (H. pylori) and early-stage stomach cancer. Researchers will analyze medical records, test results, and tissue samples from patients who have had early stomach cancer treated with a minimally invasive procedure called endoscopic submucosal dissection. The goal is to understand how the presence or absence of this bacteria and certain pathological features can help predict how the cancer will behave and what the long-term outcomes might be.
Even after H. pylori is treated, some patients still develop stomach cancer, and others experience cancer recurrence after treatment. This study aims to better understand the relationship between the bacteria's presence and the cancer's behavior, so doctors can better predict which patients are at higher risk and provide more personalized follow-up care.
You likely qualify if…
You likely don't qualify if…
If you join this study, researchers will review your medical records, previous test results for the stomach bacteria, and tissue samples from your cancer treatment. For new participants, you will have endoscopic follow-up visits at approximately 1, 2, and 3 years after your procedure to check for recurrence or new growths. The study involves no additional treatments — it is purely observational, meaning researchers are studying your existing medical information and routine follow-up care to better understand how the bacteria and cancer characteristics relate to outcomes.
AI-generated summary from trial data · Aug 5, 2026 · Not medical advice
China